Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies

Anoosha Habibi, Maryse Etienne-Julan, Emmanuelle Bernit, Maria Dimopoulou, Pagona Flevari, Ersi Voskaridou, Narcisse Elenga, Estelle Jean-Mignard, Giovanna Cannas, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 2500.

https://doi.org/10.1182/blood-2023-178198

Published: 2023

Journal Articles

Long-Term Efficacy and Safety of L-Glutamine in Preventing Sickle Cell Disease-Related Acute Complications and Hemolysis in Pediatric and Adult Patients: A Real-World Observational Study

Narcisse Elenga, Gylna Loko, Maryse Etienne-Julan, Randa Al-Okka, Ahmad M Adel, Mohamed A Yassin

Blood (2022) 140 (Supplement 1): 2560–2561.

https://doi.org/10.1182/blood-2022-170382

Published: 2022

Journal Articles

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Mariane de Montalembert, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Regine Grosse, Valentine Brousse

Blood (2022) 140 (Supplement 1): 449–450.

https://doi.org/10.1182/blood-2022-165946

Published: 2022

Journal Articles

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Frédéric Galactéros, MDPhD, Ersi Voskaridou, Anoosha Habibi, MD PhD, Giovanna Cannas, MD, Laure Joseph, MD, Gylna Loko, MD, Mariane De Montalembert, MD PhD, Narcisse Elenga, MD PhD, Malika Benkerrou, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140265

Published: 2020

Journal Articles

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Lena Oevermann, MD, Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Marie Petras, MD, Marie Belloy, MD, Narcisse Elenga, MD PhD

Blood (2018) 132 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2018-99-114441

Published: 2018

Journal Articles

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

Laure Joseph, MD, Anoosha Habibi, MD, Giovanna Cannas, MD, Stephanie Ngo, MD, Sylvain Le Jeune, MD, Ersi Voskaridou, MD, Elena Foïs, MD, Caroline Makowski, MD, Nathalie Lemonne, MD, Narcisse Elenga, MD, Yves Ville, MD PhD, Alexandra Benachi, MDPhD, Robert Girot, MD, Marina Cavazzana, MD PhD, Jean-Antoine Ribeil, MD PhD

Blood (2016) 128 (22): 1309.

https://doi.org/10.1182/blood.V128.22.1309.1309

Published: 2016

Journal Articles

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Regine Grosse, MD, Uwe Kordes, MD MRCP, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Corinne Armari-alla, MD, Narcisse Elenga, MD, Marcin Wlodarski, MD, Stephan Lobitz, MD

Blood (2016) 128 (22): 2494.

https://doi.org/10.1182/blood.V128.22.2494.2494

Published: 2016

NARROW

Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies

Long-Term Efficacy and Safety of L-Glutamine in Preventing Sickle Cell Disease-Related Acute Complications and Hemolysis in Pediatric and Adult Patients: A Real-World Observational Study

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Email alerts

ASH Publications

American Society of Hematology

Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies

Long-Term Efficacy and Safety of L-Glutamine in Preventing Sickle Cell Disease-Related Acute Complications and Hemolysis in Pediatric and Adult Patients: A Real-World Observational Study

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only